CECentral - Pain Management ActivitiesLive and Online CME/CE/CEUs for Healthcare Professionals seeking certified professional development.https://www.cecentral.com/rss2024-03-28T10:57:00+00:00℗ & ©The University of KentuckyFeedCreator 1.8 (info@mypapit.net)Q&A Session for Alcohol Use Disorder in the Hospitalized Patient2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25290info@cecentral.comAlcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and older who had AUD in the past year received any treatment in the past year and Less than 4% of people with AUD were prescribed FDA approved medications for AUD.Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and older who had AUD in the past year received any treatment in the past year and Less than 4% of people with AUD were prescribed FDA approved medications for AUD.Alcohol Use Disorder in the Hospitalized Patient2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25289info@cecentral.comAlcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and older who had AUD in the past year received any treatment in the past year and Less than 4% of people with AUD were prescribed FDA approved medications for AUD.Alcohol consumption is common and with that, alcohol use disorder (AUD) is also common. It is estimated that 20% of patients admitted to the hospital have an alcohol use disorder. Learning to diagnose AUD during a hospitalization in order to effectively manage alcohol withdrawal symptoms is vital to these patient’s health. AUD is undertreated with 7.3% of adults aged 18 and older who had AUD in the past year received any treatment in the past year and Less than 4% of people with AUD were prescribed FDA approved medications for AUD.Rapid Drug Testing and Checking2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25288info@cecentral.comIn the U.S., rapid drug checking is a relatively new harm reduction technology to identify certain contaminants in the illicit drug supply, but many healthcare providers may be unaware of these resources and/or best practices for their use.Understanding these technologies is critical to mitigating the negative impact of an unregulated illicit drug supply on people who use drugs.In the U.S., rapid drug checking is a relatively new harm reduction technology to identify certain contaminants in the illicit drug supply, but many healthcare providers may be unaware of these resources and/or best practices for their use.Understanding these technologies is critical to mitigating the negative impact of an unregulated illicit drug supply on people who use drugs. Long-Acting Injectable Buprenorphine2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25287info@cecentral.comIndividuals with OUD need more treatment options that can address problems such as: nonadherence, medication misuse/diversion/theft, access to care, and transportation limitations. Injectable monthly buprenorphine may help address several of the limitations associated with transmucosal buprenorphine. Healthcare providers, social workers, and others involved in the care of individuals with OUD need to be familiar with injectable monthly buprenorphine, the unique requirements for obtaining and administering it, and the REMS requirements to ensure its efficacy and patient safety. Individuals with OUD need more treatment options that can address problems such as: nonadherence, medication misuse/diversion/theft, access to care, and transportation limitations. Injectable monthly buprenorphine may help address several of the limitations associated with transmucosal buprenorphine. Healthcare providers, social workers, and others involved in the care of individuals with OUD need to be familiar with injectable monthly buprenorphine, the unique requirements for obtaining and administering it, and the REMS requirements to ensure its efficacy and patient safety. Harm Reduction in the Time of Fentanyl: A Canadian Perspective2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25286info@cecentral.comNorth America continues to be affected by an overdose crisis driven primarily by an increasingly toxic and unpredictable unregulated drug supply. Increasing the awareness for the role and limitations of supervised consumption sites and other novel harm reduction interventions as tools to prevent overdose deaths.North America continues to be affected by an overdose crisis driven primarily by an increasingly toxic and unpredictable unregulated drug supply. Increasing the awareness for the role and limitations of supervised consumption sites and other novel harm reduction interventions as tools to prevent overdose deaths.Q&A Session: Functional Family Therapy: A Strong Foundation for Practice with Families Who Are Stuck2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25229info@cecentral.comIf you ask most people what is important to them, family is at the top of the list.  Yet, the role of the family is often overlooked. Family is a key factor in reduction of relapse.  They are the ones most motivated because there is a lot at stake for them.If you ask most people what is important to them, family is at the top of the list.  Yet, the role of the family is often overlooked. Family is a key factor in reduction of relapse.  They are the ones most motivated because there is a lot at stake for them.Part 2: The Intersection of Criminal Legal system Involvement and Behavioral Health for Treatment2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25227info@cecentral.comIn Kentucky, the Department of Corrections is the largest provider of substance use disorder (SUD) treatment services, but behavioral health providers lack training on how criminal legal system involvement affects clients’ ability to participate in services.  It is critical to understand how involvement in the criminal legal system can be reduced through diversion to treatment as well as the complications with providing SUD services to people in government custody. In Kentucky, the Department of Corrections is the largest provider of substance use disorder (SUD) treatment services, but behavioral health providers lack training on how criminal legal system involvement affects clients’ ability to participate in services.  It is critical to understand how involvement in the criminal legal system can be reduced through diversion to treatment as well as the complications with providing SUD services to people in government custody. Part 1: The Intersection of Criminal Legal system Involvement and Behavioral Health2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25226info@cecentral.comIn Kentucky, the Department of Corrections is the largest provider of substance use disorder (SUD) treatment services, but behavioral health providers lack training on how criminal legal system involvement affects clients’ ability to participate in services.  It is critical to understand how involvement in the criminal legal system can be reduced through diversion to treatment as well as the complications with providing SUD services to people in government custody. In Kentucky, the Department of Corrections is the largest provider of substance use disorder (SUD) treatment services, but behavioral health providers lack training on how criminal legal system involvement affects clients’ ability to participate in services.  It is critical to understand how involvement in the criminal legal system can be reduced through diversion to treatment as well as the complications with providing SUD services to people in government custody. Opioid and Cannabinoid Interactions: Abuse Potential and Clinical implications2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/25225info@cecentral.comIndividuals that use opioids often use cannabinoids as well.  However, there are many unknowns regarding the safety of using both opioids and cannabinoids, particularly at the doses and via routes of administration that are common with misuse. Individuals that use opioids often use cannabinoids as well.  However, there are many unknowns regarding the safety of using both opioids and cannabinoids, particularly at the doses and via routes of administration that are common with misuse. Q&A The ADA and Its Implications for Patients with OUD: A Workshop2024-03-28T14:57:00+00:002024-03-28T14:57:00+00:00https://www.cecentral.com/activity/24803info@cecentral.comPatients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to advocate for increased access to medications for opioid use disorder and decrease in health inequities using the ADA.  Patients with opioid use disorder have a disability that is protected by the Americans with Disabilities Act (ADA), yet few patient care providers or patients are aware of what the protections are or how to file a case for an ADA violation. This talk will serve as a primer to explain how to advocate for increased access to medications for opioid use disorder and decrease in health inequities using the ADA.